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ABSTRACT
Stem cells are a unique source of self-renewing cells within
the human body. Before the end of the last millennium,
adult stem cells, in contrast to their embryonic counter-
parts, were considered to be lineage-restricted cells or inca-
pable of crossing lineage boundaries. However, the unique
breakthrough of muscle and liver regeneration by adult
bone marrow stem cells at the end of the 1990s ended this
long-standing paradigm. Since then, the number of articles
reporting the existence of multipotent stem cells in skin,
neuronal tissue, adipose tissue, and bone marrow has esca-
lated, giving rise, both in vivo and in vitro, to cell types
other than their tissue of origin. The phenomenon of fate
reprogrammation and phenotypic diversiﬁcation remains,
though, an enigmatic and rare process. Understanding how
to control both proliferation and differentiation of stem
cells and their progeny is a challenge in many ﬁelds, going
from preclinical drug discovery and development to clinical
therapy. In this review, we focus on current strategies to
differentiate embryonic, mesenchymal(-like), and liver
stem/progenitor cells into hepatocytes in vitro. Special
attention is paid to intracellular and extracellular signaling,
genetic modiﬁcation, and cell-cell and cell-matrix interac-
tions. In addition, some recommendations are proposed to
standardize, optimize, and enrich the in vitro production of
hepatocyte-like cells out of stem/progenitor cells. STEM
CELLS 2009;27:577–605
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION:T HE STEM CELL
MICROENVIRONMENT
The totipotent fertilized egg is the ultimate stem cell that
gives rise to all tissues of the developing embryo. In the
adult, ‘‘multipotent’’ stem/progenitor cells reside for a nearly
inﬁnite term at restricted locations to allow continuation of
the cycle of life [1–3]. These so-called stem cell niches have
been identiﬁed in the bone marrow [4], brain [5], skin [6], in-
testinal crypt [7], and liver [1, 8]. The original idea of a stem
cell ‘‘niche’’ evolved from the concept that stem/progenitor
cells inhabit tissues within an ‘‘inductive microenvironment’’
that directs their self-renewal, differentiation, and cell fate in
both normal physiology and disease [1, 3, 9]. Many develop-
mental regulatory signaling molecules, including Wnts, bone
morphogenic proteins (BMP), ﬁbroblast growth factors
(FGFs), Notch, and others, may play a role [1, 7, 8]. In addi-
tion to stem/progenitor cells, the niche microenvironment
comprises nonstem niche cells (e.g., stromal cells, periductu-
lar ﬁbroblasts, and stellate cells), parasympathetic nerve end-
ings and specialized extracellular matrix (Fig. 1) [1, 2, 10,
11]. Other cell-cell interactions have also been hypothesized.
The coordinated signaling between component cells and scaf-
fold, (in)direct cell-cell contacts, and integration of stem cell-
autonomous properties represent an interactive and dynamic
system, organized to facilitate cell fate decisions in a proper
spatiotemporal manner [1, 2, 8].
Historically, the developmental paradigm was that adult
stem cells were, in contrast to their embryonic counterparts,
subjected to ‘‘cell fate determinism.’’ Nowadays, new insights
on stem cell potency have challenged the latter canonical
developmental hierarchy [12]. Nevertheless, ‘‘adult stem cell
plasticity’’ still remains an obscure and rather rare phenom-
enon. The ﬁnding that at least some transitions may be
ascribed to cellular fusion events have underpinned true plas-
tic phenomena [13, 14] and has led to an outbreak of raw
headlines, utterly questioning adult stem cell versatility, for
example, ‘‘Adult Stem Cell Plasticity—Fact or Artifact?’’
[15], ‘‘Recipes for Adult Stem Cell Plasticity: Fusion Cuisine
or Readymade?’’ [16], ‘‘Adult Stem Cell Plasticity—Fact or
Fiction’’ [17], and ‘‘Stem Cell Fusion Confusion’’ [18].
Author contributions: S.S.: conception and design, manuscript writing, collection and assembly of data, data analysis and interpretation;
J.D.K.: manuscript writing, collection and assembly of data; V.R.: ﬁnancial support, critical revision of manuscript; T.V.: critical
revision of manuscript, ﬁnal approval of manuscript.
Correspondence: Sarah Snykers, Ph.D., Department of Toxicology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels,
Belgium. Telephone: 32-0-2-4774587; Fax: 32-0-2-4774582; e-mail: sarah.snykers@vub.ac.be. Received September 25, 2008; accepted
for publication November 21, 2008; ﬁrst published online in STEM CELLS EXPRESS December 4, 2008.V C AlphaMed Press 1066-5099/2008/
$30.00/0doi: 10.1634/stemcells.2008-0963
STEM CELLS 2009;27:577–605 www.StemCells.comHitherto, the answer remained an open question. The fact is
that not all cellular ‘‘redirections,’’ no matter how rare their
occurrence, might be ascribed to simple fusion events [12, 16,
19, 20]. In vitro, spontaneous fusion only occurs in coculture
models, and, even so, the frequency rate is limited to about
one fusion event per 10
3–10
6 cocultured cells [12, 20, 21]. In
addition, in vivo, regular natural fusion of stem cells with
other cell types seems unlikely because, with the exception of
the liver and the pancreas, healthy organs lack substantial
complements of polyploid cells [16]. This brings us back to
the essence of fate reprogrammation of stem/progenitor cells:
the stem cell microenvironment. In vivo, an injured environ-
ment seems most favorable for tissue replenishment by stem/
progenitor cells [16, 22, 23], although extracellular cues pro-
vided by the transplanted stem/progenitor cells (cf. the
‘‘bystander’’ effect) also may be partly accountable for ‘‘re-
covery’’ of the recipient [23, 24]. In vitro, the highest success
rates of phenotypic ‘‘diversiﬁcation’’ were gained upon mim-
icking the microenvironment (Fig. 1). It is now well recog-
nized that identiﬁcation of the in vivo signaling patterns —the
lineage-speciﬁc growth factors/cytokines and their (relative)
dose and rank of application [8]—is crucial for eliciting dis-
tinct responses from cultured stem/progenitor cells and direct-
ing lineage-speciﬁc cell growth and differentiation in vitro.
Apart from the latter cues, intrinsic cellular stress signals, ex-
ecuted by removal of stem/progenitor cells from their physio-
logical niche, may also facilitate alterations in cellular archi-
tecture and phenotype via mechanisms of ‘‘cytoskeleton
collapse’’ (Fig. 1; see also Need for Standardization, Optimi-
zation, and Enrichment) [25, 26].
In this survey, we provide an up-to-date overview on the
wide variety of experimental conditions that have been
applied thus far to trigger cultured pluripotent embryonic
stem (ES) cells, multipotent mesenchymal(-like) stem/progeni-
tor cells (MSCs), and bipotent liver progenitor cells (LPCs)
into (functional) hepatocytes (Tables 1, 2,, and 3). In princi-
ple, most approaches are based on reconstructing the in vivo
microenvironment via (a) addition of soluble medium factors
and (b) reconstitution of cell-matrix, and (c) cell-cell interac-
tions. Recently, (d) interest has also increased in chromatin
modulation as a strategy to manipulate cell fate. Constitutive
overexpression of liver-enriched transcription factor (LETF)
genes might be an alternative but has a downside too.
FROM STEM CELLS TO HEPATOCYTES:
HEPATOGENESIS IN VIVO
The microenvironment of developing hepatocytes is a
continuously changing process of successively occurring
Figure 1. Adult stem/progenitor cell environment in vivo and ex vivo. The balance between cell growth/differentiation of adult stem/progenitor
cells is regulated by a complex cross-talking network of paracrine and autocrine signals and cell-cell and cell-extracellular matrix interactions.
Abbreviation: ECM, extracellular matrix.











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































]biological events [27]. Each step of cell growth and differ-
entiation is tightly regulated by intra- and extracellular com-
munication, as well as cell autonomous mechanisms (Fig.
2). Nodal (activin), FGFs, BMP, hepatocyte growth factor
(HGF), and oncostatin M (OSM) are herein the most essen-
tial extracellular signals [2, 27–30]. At the intracellular
level, the liver-enriched transcription factors hepatocyte nu-
clear factor (HNF) 3a,b, HNF4a,H N F 1 a,b, HNF6, and
CCAAT enhancer binding protein (C/EBP) a,b act consecu-
tively, in essence, in a cross-regulatory manner, at speciﬁc
developmental stages to regulate liver-speciﬁc gene expres-
sion [27–29, 31, 32] (Fig. 2).
In brief, at the onset of liver ontogeny (approximately
rodent embryonic day [E] 8.5), speciﬁcation from endoder-
mal stem cells toward the hepatic epithelial lineages
requires, next to HNF3b and activin A signaling, signaling
from two adjacent mesodermal cell types: FGFs (FGF1 and
basic bFGF) from the cardiogenic mesoderm cells, and
BMPs (BMP2, BMP4, BMP5, and BMP7) from the septum
transversum mesenchyme [27–29] (Fig. 2). Then (approxi-
mately rodent E9.0-9.5), cells start to massively proliferate
and bud into the stromal environment of the septum trans-
versum mesenchyme. The hepatic epithelial speciﬁed cells




þ, hepatic a-fetoprotein [AFP]
þ/albumin
[ALB]
þ, and biliary cytokeratin [CK 17
þ/CK19
þ) [2, 27–
29]. At rodent E11-12, the liver primarily becomes a pri-
marily hematopoietic organ. Hematopoietic stem cells
(HSCs) originating from the extrahepatic organ colonize
the liver bud, thereby emitting a growth signal for the liver
[28, 29]. Consequently, hepatoblasts continue to proliferate
and start expressing placental alkaline phosphatase, inter-
mediate ﬁlament proteins (CK14, CK8, and CK18), c-gluta-
myltransferase, and later also a1-antitrypsin, glutathione S-
transferase P, C/EBPa, lactate dehydrogenase, and muscle
pyruvate kinase [2, 28, 29]. As commitment progresses,
three distinct cell populations are distinguished: (a) hepato-
cyte-committed cells that exclusively express hepatocyte
markers, such as AFP and ALB, (b) cholangiocyte-commit-
ted progenitor cells, expressing biliary cell markers such as
CK19, and (c) a bipotential hepatoblast population,
expressing both hepatic and biliary markers. The latter
population develops into biliary or hepatic cell lines and is
therefore considered to be the fetal source of hepatic pro-
genitor cells [2, 27, 29]. Differentiation along the cholan-
giocytic lineage is promoted by Notch signaling pathways
[27, 29, 30]. HGF, excreted by mesenchymal cells or non-
parenchymal liver cells, antagonizes the latter process,
resulting in support of growth and differentiation of the fe-
tal hepatocytes. The hormone insulin synergistically pro-
motes this effect [2, 28, 33]. Subsequently, cooperative
action of OSM, mostly produced by HSC, and glucocorti-
coids induces partial hepatic maturation and suppression of
embryonic hematopoiesis [2, 27, 28, 33] (Fig. 2). OSM
alone fails to induce differentiated liver phenotypes, imply-
ing the essence of glucocorticoids as triggers for hepatic
maturation [28]. Upon progression of the differentiation
stage, the gene expression proﬁle of fetal liver epithelial
cells acquires a more mature phenotype. In parallel, the
percentage of bipotent cells is markedly reduced. At this
point, although cells continue to proliferate, most of them
are unipotent and irreversibly committed to either the hepa-
tocytic or cholangiocytic lineage [2, 27, 29]. Complete
functional hepatic maturation ultimately takes place after
birth upon coassistance of HGF, produced by the surround-








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































]Key signaling and molecular cross-talk events are thus pat-
terned to occur in the right place at the right time [8]. Interac-
tions between these various compartments accomplish
homeostatic regulation of stem/progenitor cell functioning in
vivo [2, 8]. Consequently, identiﬁcation and simulation of
these in vivo signaling patterns might comprise an approach
to contribute to fate reprogrammation of stem/progenitor cells
in vitro.




ES cells spontaneously differentiate into cell types of the
three germ layers, including hepatocytes, upon removal of
leukemia inhibitory factor and feeder layers [34–37]. The
processes of lineage establishment in developing embryoid
bodies (EBs) appear to follow the events of embryogenesis,
suggesting that ES cells can recognize and respond to the sig-
nals regulating embryonic development. The drawback is the
yield of mixed cell types.
Addition of Soluble Medium Factors (Growth Factors/Cyto-
kines/Corticosteroids/Hormones). The use of growth factors
and cytokines is pivotal for hepatic growth of ES cells in
vitro. Hormones and corticosteroids have a supporting role
(Table 1).
Basically, activin A enriches ES cell cultures for endoder-
mal populations [38, 39] and deﬁnite endoderm [40]. FGFs,
but not BMP, are effective in mediating early hepatic differ-
entiation, yet the choice of the most suitable FGF type
depends on the species involved [41, 42]. HGF supports a
midlate hepatic phenotype (e.g., ALB, dipeptidyl peptidase IV
expression) [37, 43], but fails to induce functional maturation
[34, 43]. Stepwise addition of FGF, HGF, and a mixture of
insulin-transferrin-sodium selenite (ITS), dexamethasone, and
OSM, on the other hand, seems successful [44–46]. Fine-tun-
ing of the latter sequential strategy might even result in 70%–
80% purity of ES cell-derived hepatocytes/hepatic progenitors
within the culture system [47, 48]. Inherent to most differen-
tiation protocols is the coexposure to serum. It contains hor-
mones, growth factors, and other undeﬁned substances that
might contribute to stochastic differentiation of pluripotent ES
cells [49, 50]. Nowadays, however, many efforts are being
made to work under serum-free conditions. In particular, the
use of serum-replacement factors has become a promising
trend [47, 48, 51].
Reconstruction of In Vivo Cell-Matrix and Cell-Cell
Interactions. Imitation of the ontogenic scaffold (particu-
larly collagen) [42, 50, 52–58] and coculture with hepatic
and nonhepatic cell types might provide an optimal in vitro
environment to promote hepatogenic differentiation in ES
cell and other stem cell cultures [49, 59]. However, intimate
physical cell contact may result in cell fusion and requires
highly sophisticated techniques to separate distinct cell pop-
ulations. Hence, differentiation protocols currently use semi-
permeable membranes or ﬁltered cell-conditioned media
[60]. Fetal liver cells probably represent the most suitable
cultivation partners [49, 59], because they, unlike cardiac




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Snykers, De Kock, Rogiers et al. 595
www.StemCells.comDetermination of Cell Fate via Genetic Modiﬁcation.
(a) LETFS overexpression. HNF3b functions as a vital regu-
lator of the initial intracellular signaling pathways in liver de-
velopment/regeneration [28, 32] (Fig. 2). In addition, it may act
as a driving force of ES cell differentiation along the hepatic
lineage. In this context, HNF3b-transfected ES cells acquire a
hepatic phenotype, more efﬁciently and far earlier than their
untransfected counterparts [62–64]. Using this approach, ES
cell differentiation in culture is in fact driven by the same tran-
scriptional events as seen in early liver organogenesis in vivo.
Hepatic gene expression and also hepatocellular functionality
are found to be directly related to HNF3b levels [62]. A stated
alternative is the recombinant expression of E-cadherin, most
likely because adherens junction-mediated intercellular cou-
pling has an integral role in hepatocyte functioning [52]. Major
drawbacks of the constitutive overexpression of regulatory
(transcription) factors are the risks of both unpredictable and
nonintended gene upregulation in vitro.
(b) Epigenetic modiﬁcation. The actual idea of changing
cell fate via direct interference with the local chromatin struc-
ture of plastic cells was introduced only a few years ago. In
2003, ES exposure to 5 mM sodium butyrate led to 10%–
15% enrichment with pure hepatic cells [65]. Lately, priming
with alternating concentrations of sodium butyrate (0.5–1
mM) in the presence of activin A resulted in 10%-70%
enrichment [51]. Basically, combined application of epige-
netic modiﬁcation and stepwise exposure to cytokine stimuli
contributed considerably to homogeneity of the end popula-
tion and acquirement of hepatic functionality [51]. Hitherto,
both successful and failed differentiations were obtained using
histone deacetylase inhibitors (HDACis), rendering their hepa-
totrophic effect ambiguous [43, 57]. Plausible explanations
are described in From Stem Cells to Hepatocytes: Current
Characterization Strategies and Their Limitations.
Multipotent Mesenchymal Stem Cells
Unidirectional/downstream differentiation into other mesen-
chymal cell types, such as adipocytes, chondrocytes, and
osteoblasts readily occurs in the presence of a simple cocktail
of growth factors and nutrients [66]. Successful bypassing of
lineage borders depends mainly on multistep processes in a
coordinated, synergistic signaling network (Table 2).
Addition of Soluble Medium Factors (Growth Factors/Cyto-
kines/Corticosteroids/Hormones). Multipotent adult progen-
itor cells (MAPCs), discovered by Verfaillie and coworkers,
were the ﬁrst plastic cells found within adult bone marrow
that gained the ability to undergo hepatic differentiation.
Using combined exposure to FGF þ HGF þ ITS þ dexa-
methasone, MAPCs transformed into cells with morphologi-
cal, phenotypic, and functional characteristics of hepatocytes
[67]. Yet, the resultant population was far from homogene-
ous. Signiﬁcantly optimized differentiation was obtained via
exposure of bone marrow stem cells to the same hepatogenic
factors, but in a time-speciﬁc sequential manner, reﬂecting
their secretion pattern during the hepatogenesis in vivo.
Figure 2. Schematic presentation of fetal liver development (modiﬁed from [2]). The establishment of a fully functional liver architecture is not
accomplished before postnatal stages and follows upon a sequential array of tightly regulated intra- and extracellular signaling pathways, includ-
ing liver-enriched transcription factors (LETFs) and growth factors, cytokines, glucocorticoids and hormones, respectively. To distinguish the
level of expression and/or regulating role among diverse LETFs, different letter sizes are used. Abbreviations: ALB, albumin; AFP, a-fetoprotein,
BMP, bone morphogenic proteins; C/EBP, CCAAT enhancer binding protein; CK, cytokeratin; CM, cardiogenic mesoderm; E, embryonic day in
rodent liver development; FGF, ﬁbroblast growth factors; GGT, c-glutamyltransferase; HGF, hepatocyte growth factor; HNF, hepatocyte nuclear
factor; OC-2, Onecut transcription factor; ST, septum transversum; TGF, transforming growth factor.
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tured a highly differentiated hepatic phenotype and function-
ality, including inducible cytochrome P450 (CYP)-dependent
activity [68]. Thus far, several research groups have revealed
expression of distinct hepatocyte markers and functions, that
is, ALB and urea secretion, glycogen storage, and low-den-
sity lipoprotein uptake upon stimulation of MSCs with hepa-
togenic factors exclusively, added either as a mixture (FGF
þ HGF [69–71]; FGF þ HGF þ OSM [72]) or separately
(HGF [73]; HGF/OSM [74]; FGF/HGF/OSM [75]). Also
combinations thereof (FGF þ HGF followed by OSM [76,
77]) have been applied. In contrast, others emphasized the
necessity of supplementary differentiation-inducing factors
to enforce functional hepatic conversion of MSCs [78]. Basi-
cally, soluble medium factors such as dexamethasone, ITS,
and nicotinamide synergistically affect the hepatic driving
pathways [79]. In sharp contrast to the critical role of serum
in MSC expansion and until recently in ES cell differentia-
tion, serum-free conditions have been successfully applied
on a routine basis for hepatic differentiation of MSCs [75,
77–79].
Reconstruction of In Vivo Cell-Matrix and Cell-Cell
Interactions. Cocultures of stromal bone marrow cells with
primary hepatocytes were at ﬁrst designated to develop
long-term functional hepatic in vitro models [80]. Jagged1
protein was considered responsible for the benign effects on
hepatocyte differentiation by mediating differentiation
events via the Notch signaling pathway [80, 81]. Later,
J a g g e d 1a n dN o t c hw e r ec o n s i d e r e de s s e n t i a li nd r i v i n g
bone marrow progenitors toward hepatocyte-lineage cells
[81]. In a recent study by Lange et al. [78], coculture with
liver cells was claimed to be the sole trigger able to shift
MSC into cells with a hepatobiliary phenotype. The
impaired differentiation capability of the chosen clonal
MSCs or the high purity of high passaged MSCs (thus not
contaminated with hematopoietic stem cells) [82, 83] was
held responsible for failing growth factor-stimulated hepatic
differentiation.
Another critical factor affecting cellular differentiation
status is the spatial distribution between cells. Differentiation
is usually initiated upon 60%–100% conﬂuence (Table 1).
Signiﬁcantly promoted hepatic differentiation in areas of high-
est cellular density (maximal cell-cell contact) versus that in
lower cellular density [67, 68, 74, 76, 82, 84] emphasized the
relevance of intercellular communication during differentia-
tion processes. Minor roles are ascribed to the type of coat-
ings used. The natural scaffold collagen turns out to be most
effective [68, 84].
Determination of Cell Fate via Genetic Modiﬁcation.
(a) LETFS overexpression. To the best of our knowledge,
only one study thus far has investigated the putative inductive
effect of LETFs on hepatic differentiating MSCs. More spe-
ciﬁcally, Talens-Visconti et al. [77] conﬁrmed the contribu-
tion of C/EBPb in driving adipose tissue-derived stem cells
(ADSCs) and bone marrow-derived MSCs towards hepatic
cells; yet, only trivial roles were ascribed to C/EBPa.
(b) Epigenetic modiﬁcation. Epigenetic modiﬁcation may
contribute to overcome cell fate. determinism of MSCs. As
such, we found previously that addition of 1 lM trichostatin
A (TSA) to cultured human (h) MSCs, pretreated for 6 days
with hepatogenic stimulating agents, triggers their ‘‘transdif-
ferentiation’’ into cells with phenotypic and functional char-
acteristics similar to those of primary hepatocytes [84]. In
line with our results, Seo et al. [79] showed enhanced he-
patic differentiation upon addition of 0.1% dimethylsulfox-
ide (DMSO) to hADSCs, prestimulated for 10 days with a
mixture of hepatogenic cytokines. Recently, DNA methyl
transferase inhibitors (DNMTis), either alone or combined
with HDACis, also were introduced to alter cell fate [85–
88]. Basically, DNMTis function as preconditioning agents
before hepatic differentiation [87–89], whereas HDACis act
as stimulants during or after differentiation [68, 79, 90, 91].
In general, chromatin remodeling seems, thus, to be a poten-
tial innovative strategy to overcome cell fate determinism
and favor lineage-speciﬁc differentiation. This ﬁeld is
expected to emerge in the coming years.
Bipotent Liver Progenitor Cells
LPCs mainly comprise a bipotent progenitor cell population
within the liver [92]. Their biliary/hepatic cell fate highly
depends on cooperative cross-talks between extrinsic and
intrinsic signaling pathways. Soluble factors, in particular,
may execute pleiotropic effects (Table 3).
Addition of Soluble Medium Factors (Growth Factors/Cyto-
kines/Corticosteroids/Hormones). Differentiation of LPCs
into either the biliary or hepatic lineage greatly depends on
the type of growth factor/cytokine used. (a) In midphase fe-
tal liver, transforming growth factor (TGF) b promotes LPCs
to undergo biliary differentiation [93], whereas HGF, FMS-
like tyrosine kinase 3, stem cell factor (SCF), epidermal
growth factor (EGF) [93–96], and members of the Gp130 re-
ceptor family, including OSM [97, 98], promote their initial
hepatic differentiation and maturation, respectively. FGF
propagates embryonic liver cultures toward hepatic progeni-
tors. In this sense, FGF1 and FGF4 enrich for bipotential he-
patic progenitors, whereas FGF8 further promotes the former
enrichment for unipotential hepatocyte progenitors [99]. (b)
In neonatal and adult rodent liver, HGF, FGF (FGF-1, FGF-
2, and FGF-4), EGF, SCF, and TGFa,b might simultaneously
play a central role in activation/proliferation, maintenance,
and differentiation of LPCs such as liver epithelial cells and
oval cells [100–103]. Some exceptions do occur, however
[104].
Guidance of their cell fate by corticosteroids and hor-
mones is less unidirectional. For example, dexamethasone
upregulates the number of both hepatic- and bile duct-like
cells in LPCs derived from midphase fetal mouse liver tissue
[93]. Despite this scattered effect, when dexamethasone is
accompanied by sodium butyrate, cultured oval cells shift
solely toward the hepatocyte lineage [105]. Furthermore,
growth-promoting effects have been ascribed to insulin, trans-
ferrin, a-tocopherol acetate, selenite, linoleic acid, nicotina-
mide, and hydrocortisone [95, 100–102, 106].
Reconstruction of In Vivo Cell-Matrix and Cell-Cell
Interactions. The decisive factor of the microenvironment
in directing the liver ontogeny underlines the importance of
local cell and tissue paracrine signaling. In the context of this
rationale, cocultivation of LPCs with stellate cells and mesen-
chymal feeder layers, including embryonic chick lung mesen-
chyme, growth-inhibiting embryonic STO ﬁbroblast, or mes-
enchymal NIH3T3 ﬁbroblast feeder layers, stimulate
differentiation along the hepatic lineage [97, 101, 103, 104].
Cultivation in a three-dimensional collagen gel I matrix cul-
ture system provides further support [104]. In turn, removal
of feeder layers and introduction of Matrigel leads to the for-
mation of bile structures [104].
Besides signals secreted by the surrounding environment,
cell density may also trigger differentiation. In essence, the
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ﬂuence [107, 108].
Determination of Cell Fate via Epigenetic
Modiﬁcation. Long before their ﬁrst introduction as cell
fate modulators in ES and MSC cultures, epigenetic modiﬁ-
cation was found to actively contribute to the regulation of
liver stem cell responses. The most commonly used HDA-
Cis in LPC cultures are DMSO and sodium butyrate [104–
106, 108–111]. Depending on the cell type involved and
the developmental/differentiation stage of the cells, these
HDACis differentially direct cell fate determination. The
following classes of HDACis can be distinguished on the
basis of their potency to stimulate biliary and/or hepatic
differentiation [112]: (a) hepatic-stimulatory sodium butyr-
ate in FNRL cells [110] and WB-F344 cells [109]; (b) bili-
ary- and hepatic-inducing DMSO in HepaRG [113]; and (c)
hepatic-stimulatory DMSO and biliary-inducing sodium bu-
tyrate in explants of mouse E9.5 liver diverticulum [93]
and in primary cultures of rat E12 liver cells [97].
Recently, priming of liver MSCs with the DNMTi 5-azaciti-
dine was also found to trigger functional hepatic differen-
tiation [114].
FROM STEM CELLS TO HEPATOCYTES:
CURRENT CHARACTERIZATION STRATEGIES
AND THEIR LIMITATIONS
Stem cell-derived hepatocyte-like cells may be characterized
in vitro at four levels: morphological, RNA, protein, and
activity levels. Usually, the analytical work is limited to the
elucidation of (a) endodermal/hepatogenic RNA transcripts
via (quantitative) reverse transcriptase-polymerase chain reac-
tion and (b) proteins by immunoﬂuorescence. The most stud-
ied endodermal markers include LETFs (HNF1a,b, HNF3b,
HNF4a, and C/EBPa,b), plasma proteins (AFP, ALB, trans-
thyretin [TTR]), and cytoskeletal proteins (CK18, CK8)
(Tables 1–3). A minority of studies have examined the
expression of CYPs and other ‘‘late’’ enzymes such as trypto-
phan 2,3-dioxygenase (TO) and tyrosine amino transferase
(TAT).
The following three features inherent to hepatic stem cell
transitions need to be taken into account to perform accurate
phenotyping. (a) The differentiation of stem/progenitor cells
toward the hepatocyte lineage often involves uncontrolled
processes, resulting in a heterogeneous cell population.
Genes such as TAT [115], phosphoenolpyruvate carboxyki-
nase [116], and LETFs [117–120] are also expressed in other
somatic cells such as lung, intestine, pancreas, and kidney
and thus cannot be considered as ‘‘true’’ hepatocyte markers.
In addition, genes such as AFP and TTR are both expressed
in liver tissue and in the extraembryonic yolk sac [121,
122]. Hence, exclusive analysis of one of the latter markers
cannot count as proof for a genuine hepatic phenotype. The
need thus arises to identify genes that are predominantly
expressed in the liver and not in other tissues, enabling an
accurate follow-up of the differentiation process and precise
characterization of the end populations. In mouse, CYP7A1
is solely expressed in the liver and not in the yolk sac tissue,
fulﬁlling its function as a reliable hepatocyte marker [36].
Alternatively, the synthesis of urea is a privileged function
of hepatocytes [123, 124].
(b) The differentiation of hepatoblasts into hepatocytes
is a steady process. It is known that embryonic, fetal, and
adult hepatocytes differ in their molecular phenotype [1, 2].
Basically, hepatogenesis in vivo implies serial expression of
early (HNF3b, AFP, and TTR), midlate (HNF1a,H N F 4 a,
ALB, and CK18), and late (TO, TAT, C/EBPa,a n dC Y P s )
markers [28, 30–32, 125, 126]. Yet, some genes such as
TTR and ALB are ﬁrst expressed in early-midlate embryos
and maintain expression in fetal and adult hepatocytes
[126]. Positive expression of these genes may not enlighten
the present differentiation state properly. AFP, on the other
hand, is expressed very early in embryonic development
and during the fetal stages. Its expression gradually levels
off with increasing development and disappears entirely in
adult life [125]. AFP thus represents a reliable marker to
discriminate between distinct developmental stages. Alterna-
tively, most, but not all, metabolic and detoxifying enzymes
do not become functional before birth. Indeed, during the
terminal step of liver organogenesis, the liver becomes a
functional, metabolic organ: hepatocytes start to both con-
trol the levels of metabolites and serum proteins in the
bloodstream and express numerous new genes and proteins
related to speciﬁc functions of the adult liver [32, 123,
124]. Therefore, to state the differentiation stage of the re-
sultant hepatocyte-like cells, functional assays for enzymes
need to be carried out. At present, functional analysis is par-
ticularly focused on glycogen uptake, urea metabolism, and
ALB secretion. Only a little attention has been paid to other
metabolic functions, including CYP450-dependent activity
and responsiveness to prototype inducers such as phenobar-
b i t a l( h u m a nC Y P 2 B 6a n dC Y P 3 A 4a n dr a tC Y P 2 B 1 / 2 ) ,
rifampicin (CYP3A4), and 3-methylcholantrene (human and
rat CYP1A1/2). If one bears in mind that inducible P450-
dependent activity is considered to be a key determinant of
the functional hepatic phenotype [123, 127], characteriza-
tion must encompass the above-mentioned metabolic func-
tionality assays as well.
(c) The ultimate proof of functional hepatic behavior is
no doubt in vivo transplantation of ex vivo generated stem
cells-based hepatic cells in (immunodeﬁcient) animal models
with liver injury [58, 70, 79, 82, 83, 87, 128]. Examples of
recipients permissive for engraftment of both allogeneic and
xenogeneic cells are partially hepatectomized Pfp/Rag2
 / 
[82]/nude [79] mice, carbon tetrachloride-injured severe
combined immunodeﬁcient (SCID) mice, and urokinase-type
plasminogen activator
þ/þ/nonobese diabetic-SCID mice [79,
128, 129]. Positive homing, engraftment, repopulation, and
functional maturation are basically explored by means of
molecular imaging techniques, immunohistochemistry, in
situ hybridization, and serology [58, 70, 79, 82, 83, 87, 128–
130]. Despite seemingly irrefutable evidence that stem/pro-
genitor cells could contribute to liver reconstitution, caution
should be taken with production of false-positive results
owing to application of inaccurate labeling techniques [131].
Also, one should keep in mind that, apart from generating
fully functional stem cell-derived hepatocytes, other mecha-
nisms including the bystander effect, fusion (cf. Introduc-
tion), partial transdifferentiation, and horizontal gene transfer
[128, 129] might be responsible. For a more scrupulous
insight in this complex matter, we refer the reader to Hengs-
tler et al. [129].
In brief, accurate hepatic phenotyping in vitro should
encompass the molecular analysis of a set of (non)speciﬁc
hepatic markers in combination with ammonia formation and
inducible CYP-dependent metabolism as functionality tests.
Conﬁrmation of the in vitro obtained results via rigorous in
vivo tools might shed light on the therapeutic potential of
stem/progenitor cells in various acute and chronic liver
disorders.
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Need for Standardization, Optimization,
and Enrichment
ES cells harbor a unique pluripotent versatility compared with
other fetal and adult multi- or bipotent stem/progenitor cell
populations. They possess the unrestricted capacity to form
embryonic and adult cell types, thereby reﬂecting the distinct
developmental stages in vivo. Yet, the use of ES cell/EB tech-
nology encounters a complex differentiation environment,
lack of organization, and inherent heterogeneity of the system
[132–134]. In addition, although EBs may form functional
and specialized cell types, including hepatocytes, the differen-
tiation efﬁciency in number of lineage-speciﬁc cell types
obtained is rather low [35, 135]. Culture of EBs in the pres-
ence of (a) differentiation inducers or (b) biologically derived
signals (e.g., conditioned medium or puriﬁed growth factors)
or other lineage-selective agents have been used to enrich for
speciﬁc cell populations [133]. Thus, high-purity (70%–80%)
ES cell-derived hepatocyte cultures have recently been pro-
duced on subculture and ﬁne-tuning of the order/type of cyto-
kine exposure [47, 48]. Yet, spontaneous differentiation is still
predominant in many differentiation protocols. Differentiation
is thus a default pathway of ES cells rather than replication.
The opposite holds for adult stem cells [3]. For this reason,
the use of adult stem/progenitor cells is often considered as a
potential alternative. Basically, LPCs in culture differentiate
either into hepatocytes, bile duct, or both (bipotency) [92, 97,
98, 136, 137]. The choice of matrices is the most important
determinant for the direction taken. Lately, evidence has been
provided that mesenchymal(-like) stem/progenitor cells from
various sources (bone marrow, adipose tissue, skin, placenta,
and umbilical cord) could occasionally overcome lineage bor-
ders and differentiate into endodermal (hepatocytes) and ecto-
dermal (neural cells) cell types after speciﬁc in vitro induction
[69, 74–76, 138–140]. It has now become clear that next to
identiﬁcation of hepatogenic cytokines or growth factors, their
concentrations, mode of presentation, and order of application
[8] also are crucial for hepatic differentiation and subsequent
maturation into functional hepatocytes in vitro. As such, se-
quential exposure of bone marrow MSCs to hepatogenic fac-
tors reﬂecting their secretion pattern during liver embryogene-
sis in vivo results in a homogeneous population of functional
hepatocytes. A downside of adult stem cell technology, how-
ever, is the level of reproducibility. Indeed, we found that
only 25% of the bone marrow hMSC samples processed were
‘‘plastic’’ and consequently adopted a functional hepatic phe-
notype (intralaboratory variability). A number of unknown
and consequently insufﬁciently controlled variables could be
responsible. For example, the differentiation potential of MSC
might depend on the following:
(a) The donor. Age, gender, lifestyle (e.g., smoking, alcohol
consumption, or drug abuse, health condition (health/dis-
ease), intake of pharmaceutical agents, genetic differences,
and others [141]. For example, the yield of MSCs within
bone marrow is inﬂuenced by age, gender, the presence of
osteoporosis, and prior exposure to high-dose chemother-
apy or radiation [142]. In addition, both the differentiation
and self-renewing capacity of bone marrow and liver MSCs
was often, although not exclusively [143], found to level
off with age [141, 142, 144]. In contrast, the adipogenic and
myogenic differentiation ratios of ADSCs are not affected
by the donor’s age [142]. To date, little is known about the
relationship between disease (cancer) and stem cell behav-
ior [142]. Yet, ADSCs derived from patients with gastric
cancer were found to retain their endodermal differentiation
potential [142, 145].
(b) The starting material. The harvest tissue varies, and the
original characteristics of the starting material are often
poorly deﬁned (e.g., phenotypic proﬁle, heterogeneity/
conformity, and passage number). Phenotypic instability
and plastic variability are inherent characteristics of
MSCs [141, 146–148]. In this context, individual clones
of cell lines derived from MSCs have different potentials
for differentiation, indicating different stages of determi-
nation and levels of plasticity. Physiological alterations,
resulting from exposure of clonal MSCs to a speciﬁc
microenvironment during both proliferation and differen-
tiation, may induce heritable and epigenetic cellular pre-
conditioning, altering their original phenotype and
manipulating their predestined cell fate [147]. In this
regard, it was previously shown by DiGirolamo et al.
[147] that some of the clonally derived MSCs from a sin-
gle mother colony, expanded in separate cultures and sub-
jected to identical osteogenic conditions, could efﬁciently
differentiate into osteoblasts whereas others could not.
This study clearly illustrates that clonal daughter cells,
even when derived from a single mother cell, may have a
different(ial) potential in response to soluble factors. The
ambiguous deﬁnition of starting cell material remains a
key obstacle for in vitro purposes and might even explain
the global nonreproducibility or discrepancies in inter-
and intralaboratory results reported thus far.
(c) The technology used. From an extensive review of the
current literature, it appears that great variety exists
among strategies to isolate, purify, expand, and differenti-
ate postnatal stem cells. MSCs lack well-deﬁned charac-
terization and common surface markers that allow
accurate isolation via ﬂuorescence-activated cell sorting
(FACS). For this reason, bone marrow MSCs are usually,
but not exclusively, isolated via the plastic adherence
technique. A major drawback of this strategy is its hetero-
geneous outcome, yielding a phenotypically mixed ﬁbro-
blastoid cell population [141, 146, 148–150], often
contaminated with hematopoietic cells at low passages
[147, 151]. Basically, heterogeneity of initial populations
hinders interpretation and reciprocal comparison of results
among different research groups. Also, molecular cues
necessary to enforce in vitro differentiation are complex
and therefore are not easily identiﬁable or reproducible
[152].
(d) Stress. Architectural and phenotypic diversiﬁcation in
response to stress might be misinterpreted as a true trans-
differentiation phenomena. In fact, stem/progenitor cells
removed from their natural niche and subsequently grown
in a chemical ex vivo environment emit intrinsic (cellu-
lar) and chemical stress signals that in turn could lead to
cytoskeletal collapse or pseudo-alchemical transitions [25,
26]. Unraveling the mechanisms underlying current suc-
cessful and failed occurrences of adult stem cell plasticity
and transdifferentiation is a complex and speculative
undertaking that goes far beyond the scope of this review.
Yet, we emphasize caution in interpreting data as sponta-
neous transitional processes.
It is conceivable that the factors enumerated above are
only in part responsible for the variation in results observed in
our studies and those of others. In this regard, it was postulated
that phenotypic heterogeneity is intrinsic to stem cells because
of their asymmetric self-renewal/differentiation potential.
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application (potential) of adult stem cells is the development
of high-throughput scaling procedures. Today, most strategies
to control and manipulate the cellular microenvironment of
undifferentiated stem cells and their differentiated progeny are
optimized on a laboratory scale. To be of pharmaceutical rele-
vance, miniaturization and scaling up toward industrial needs
are obligatory. In this context, bone marrow as source of
hMSCs might not be ideal. Indeed, traditional bone marrow
procurement procedures are risky for the patient and, in addi-
tion, bone marrow is also not readily available and yields
only low numbers of multipotent stem cells upon processing
[153]. A more easily accessible and readily available source
of MSCs is human adipose tissue [75, 77, 78, 154] or human
skin. These sources have the additional advantage that they
may be obtained from healthy volunteers of diverse ages and
gender. For these reasons, the latter alternative MSC sources
are currently being explored.
Epigenetic Modiﬁcation under Discussion?
Another point of interest is the role of epigenetic modiﬁers,
particularly HDACis, in mediating hepatic-conditioned post-
natal progenitor cells toward fully functional hepatocytes. In
general, epigenetic modiﬁers affect a broad variety of cellular
processes, including cell cycling, differentiation, and apopto-
sis [155–158]. For example, previous ﬁndings in our labora-
tory indicated that epigenetic alterations may represent a valu-
able approach to develop phenotypically stable primary
hepatocyte cultures. It was revealed that addition of TSA to
isolated primary hepatocytes impedes G0/G1 cell cycle transi-
tion and consequently favors the maintenance of hepatocellu-
lar functionality in vitro [155, 156, 158, 159]. Given this prin-
ciple and the fact that covalent histone modiﬁcation is central
in processes determining lineage-speciﬁc gene expression and
cell fate decisions [160, 161], we exposed postnatal bone mar-
row MSCs to TSA to obtain well-functioning mature hepato-
cytes. Critical factors in this process are onset of exposure,
dose, and environmental conditions (cell-cell contact and cell
densities) [155, 157, 158] as discussed in the following.
(a) Timing. Timing seems most essential in transdifferentia-
tion processes. In this regard, addition of 1 lM TSA to
undifferentiated bone marrow hMSCs and 0- to 5-day pre-
conditioned bone marrow hMSCs resulted in massive cell
death. On the other hand, hMSCs prestimulated with hep-
atogenic factors for at least 6 days before addition of 1
lM TSA underwent successful hepatic differentiation.
Similar results were found by Seo et al. [79]. The impor-
tance of timing is also supported by the signiﬁcant num-
ber of failed transdifferentiation experiments, producing
nonhepatocyte-like cells [162–165]. In some cases, failure
could be ascribed to inaccurately timing of exposure and
determined concentrations.
(b) Dosage. Determination of the HDACi concentration that
induces cell cycle arrest is another crucial factor, as the lat-
ter is generally a prerequisite for differentiation in vitro
[166]. In primary hepatocyte cultures, differentiation and
proliferation exclude each other [167]. Concentrations
higher than this critical value may result in massive cell
death. In preliminary experiments on bone marrow hMSCs,
5–25 lM TSA was found to be cytotoxic whereas 1 lM
TSA, added from the 6th day of differentiation on, sup-
ported long-term culture and suppression of proliferation.
Yet, at the molecular level a rather high apoptotic level was
revealed. It was thought to be conceivable that TSA under
hepatic-stimulating conditions selectively induced apopto-
sis of non(hepatic) differentiating cells, and simultaneously
promoted the survival of hepatic differentiating cells.
Although this is just a hypothesis and thus not based on
stated evidence, it does stress the importance of timing and
dose optimization of HDACis.
(c) Biotransformation. TSA is metabolically instable and
undergoes intensive phase I biotransformation in primary
rat hepatocytes [168]. With a 30-min incubation time, vir-
tually all TSA is metabolized into inactive metabolites. It
might thus be optional to use HDACi compounds that are
more metabolically stable than TSA [169]; however, the
latter only becomes an issue when stem cell-derived hepa-
tocytes acquire metabolic activity.
Another point that can be raised here is the fact that
HDACis, being modulators of chromatin, are by nature con-
sidered to be genotoxic. To date, data available in the litera-
ture are scarce. However, the genotoxic factor may have im-
portant consequences once one aims to use HDACi/DNMTi-
treated hepatocytes in cell therapy or transplantation.
PERSPECTIVES
From the discussion in From Stem Cells to Hepatocytes: Cur-
rent in Vitro Differentiation Strategies and From Stem Cells
to Hepatocytes: Current Characterization Strategies and Their
Limitations, it becomes clear that standardization of the pro-
duction of functional hepatocytes out of postnatal progenitors
and improvement of the hepatic potency of the initial progeni-
tor population are tasks for the future. Here we state some
ideas that may help to guide future stem cell research.
(a) A precise characterization of the undifferentiated initial
cell populations is of utmost importance for future exploi-
tation of stem cell technology. Phenotyping based on sur-
face markers has thus far been insufﬁcient. Instead,
characterization should be performed at morphological,
molecular, and functional levels. However, if the hypothe-
sis that heterogeneity is inherent to stem cells is true,
efforts hereto may be futile. With microarray analysis of
gene expression pattern(s) and proteomics we will learn
more. It also remains to be clariﬁed whether physiological
markers of MSCs and LPCs become lost or undergo
changes during isolation and expansion/subculture proce-
dures. Aging and stress during growth and subculture
might also affect the phenotype of progenitors [141, 170–
173]. Selection of reliable cell surface markers is there-
fore desirable to accurately isolate, select, and purify
well-deﬁned populations of plastic progenitors via FACS.
Public accessibility of phenotypic proﬁling via databases
and the Web may facilitate standardization and compara-
tive inter- and intralaboratory studies.
(b) Stem cells differ signiﬁcantly in their surface receptor
expression proﬁles for cytokines/growth factors at succes-
sive developmental stages [8,27–29,31–33]. Dosage, tim-
ing, and combinations of cytokines/growth factors should
thus be ﬁne-tuned according to the differentiated state and
type of stem cell involved. The suitability of epigenetics
to promote hepatic (trans)differentiation requires a deli-
cate balance between biological activity, pharmacokinetic,
and toxicological characteristics; proliferation/ differentia-
tion; and ﬁnally apoptosis/cell survival. Successful
improvement of the hepatocellular phenotype and func-
tionality of stem cell cultures relies, as is the case for pri-
mary hepatocyte cultures, on appropriate selection of type
of epigenetic modiﬁer applied and optimal ﬁne-tuning of
its dose and timing of exposure [163].
600 Hepatic Potency of Stem Cells: State of the Art(c) Another major consideration is the dichotomy between
hepatocyte proliferation and expression of differentiated
functions (overview in [166]). In contrast to the in vivo
situation, in which cellular proliferation and differentia-
tion go hand in hand, in vitro differentiation is mostly
associated with cell cycle arrest (with the exception of
some in vitro cultured LPCs) [102, 103]. Most commonly,
cells exit from the cell cycle and then undergo differentia-
tion, resulting in either a terminal, irreversible cell spe-
cialization or a particular developmental step in the life
cycle [166]. Hence, the dosage and combination of solu-
ble medium additives should be ﬁne-tuned, according to
this dichotomy between proliferation and differentiation
of the cells.
(d) Finally, in addition to variability at the in vitro level, it
should be clariﬁed whether or not the multipotency of
stem/progenitor cells signiﬁcantly depends on the donor’s
proﬁle [141, 171, 174]. Simple questions on the effect of
age (young or elderly donors), lifestyle (e.g., smokers or
nonsmokers), health condition, and other factors should
be answered before practical application is considered.
In conclusion, a more scrupulous understanding of the
instructive signals emanating from the stem cell niche, to-
gether with a deeper analysis of cell-intrinsic mechanisms
governing replication versus differentiation-inducing sig-
nals, is needed to reliably expand and differentiate stem/
progenitor cells. Identiﬁcation of reliable surface markers,
useful for accurate and efﬁcient isolation of plastic progeni-
tor cells may upregulate the current hepatic potential of
MSC and eventually serve to construct efﬁcient and standar-
dized devices that enable speciﬁc direction of MSCs and
other progenitors towards the hepatocyte lineage. Standardi-
zation is, in any case, a sine qua non for prospective pre-
clinical and clinical purposes of stem cells and their differ-
entiated progeny.
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